Cargando…

PPARβ/δ a potential target in pulmonary hypertension blighted by cancer risk

Detalles Bibliográficos
Autores principales:	Mitchell, Jane A., Bishop-Bailey, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475847/ https://www.ncbi.nlm.nih.gov/pubmed/30351241 http://dx.doi.org/10.1177/2045894018812053

Ejemplares similares

A Role for PPARβ/δ in Ocular Angiogenesis
por: Bishop-Bailey, David
Publicado: (2008)

Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention
por: Peters, Jeffrey M., et al.
Publicado: (2015)

PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension
por: Jiang, Yanli, et al.
Publicado: (2019)

The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension
por: Harrington, Louise S., et al.
Publicado: (2010)

Skin-Targeted Inhibition of PPAR β/δ by Selective Antagonists to Treat PPAR β/δ – Mediated Psoriasis-Like Skin Disease In Vivo
por: Hack, Katrin, et al.
Publicado: (2012)

Investigating the Role of PPARβ/δ in Retinal Vascular Remodeling Using Pparβ/δ-Deficient Mice
por: Ho, Sze Yuan, et al.
Publicado: (2020)

PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
por: Palomer, Xavier, et al.
Publicado: (2018)

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
por: Katsuya, Hiroo, et al.
Publicado: (2018)

Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy
por: Strosznajder, Anna K., et al.
Publicado: (2020)

PPARδ, a Potential Therapeutic Target for Heart Disease
por: Yang, Qinglin, et al.
Publicado: (2018)

Insights into the Role of PPARβ/δ in NAFLD
por: Chen, Jiapeng, et al.
Publicado: (2018)

PPARβ/δ: Linking Metabolism to Regeneration
por: Magadum, Ajit, et al.
Publicado: (2018)

The Role of PPARβ/δ in Melanoma Metastasis
por: Lim, Jonathan Chee Woei, et al.
Publicado: (2018)

PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target
por: Tesse, Angela, et al.
Publicado: (2009)

Effects of Exercise Training on PPARβ/δ Expression in Skeletal Muscle of Rats with Spontaneous Hypertension
por: YANG, MINGXUAN, et al.
Publicado: (2022)

Regulation of Cell Proliferation and Differentiation by PPARβ/δ
por: Müller, Rolf, et al.
Publicado: (2008)

Time (and PPARβ/δ) heals all wounds
por: Short, Ben
Publicado: (2009)

The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance
por: Aguilar-Recarte, David, et al.
Publicado: (2021)

Pulmonary paracoccidioidomycosis‐induced pulmonary hypertension
por: Batah, Sabrina Setembre, et al.
Publicado: (2020)

Is the maternal risk of pregnancy acceptable in patients with moderate pulmonary hypertension?
por: Rashidi, Farid, et al.
Publicado: (2021)

A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis
por: Müller, Rolf, et al.
Publicado: (2008)

Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression
por: Wagner, Kay-Dietrich, et al.
Publicado: (2019)

PPARβ/δ: Benefits in Coronary Artery Disease and Beyond
por: Leal, Viviane O.
Publicado: (2019)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis
por: Peters, Jeffrey M., et al.
Publicado: (2019)

NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
por: Mackenzie, Gerardo G., et al.
Publicado: (2008)

Preoperative pulmonary artery hypertension as a risk factor: the tip of the iceberg
por: Engin, Mesut, et al.
Publicado: (2023)

PPAR-δ in Vascular Pathophysiology
por: Wang, Nanping
Publicado: (2008)

Targeting PPARα in low ambient temperature exposure-induced cardiac dysfunction and remodeling
por: Chen, Xi-Yao, et al.
Publicado: (2021)

Chronic thromboembolic pulmonary hypertension
por: Correale, Michele, et al.
Publicado: (2015)

Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma
por: Leone, Patrizia, et al.
Publicado: (2023)

Vaticanol C, a resveratrol tetramer, activates PPARα and PPARβ/δ in vitro and in vivo
por: Tsukamoto, Tomoko, et al.
Publicado: (2010)

PPARα and PPARβ/δ are negatively correlated with proinflammatory markers in leukocytes of an obese pediatric population
por: Vargas-Sánchez, Karina, et al.
Publicado: (2020)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Pulmonary capillary hemangiomatosis: an uncommon cause of pulmonary hypertension
por: Faria, Igor Murad, et al.
Publicado: (2013)

Overdue to understand anticoagulation in pulmonary arterial hypertension
por: Parikh, Kishan S., et al.
Publicado: (2018)

Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function
por: Giordano Attianese, Greta MP, et al.
Publicado: (2015)

PPARβ/δ-dependent MSC metabolism determines their immunoregulatory properties
por: Contreras-Lopez, R. A., et al.
Publicado: (2020)

Emerging Role of PPAR-β/δ in Inflammatory Process Associated to Experimental Periodontitis
por: Di Paola, Rosanna, et al.
Publicado: (2011)

Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers
por: Nawaytou, Hythem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6iao12c0e06ktc73u3t7bdhfod